Ubs Group Ag Alpine Immune Sciences, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$17.75 - $41.6 $1.56 Million - $3.65 Million
87,666 Added 133.22%
153,473 $6.08 Million
Q4 2023

Feb 09, 2024
BUY
$8.54 - $20.22 $399,330 - $945,487
46,760 Added 245.5%
65,807 $1.25 Million
Q3 2023

Nov 09, 2023
SELL
$10.13 - $13.98 $271,514 - $374,705
-26,803 Reduced 58.46%
19,047 $218,000
Q2 2023

Aug 11, 2023
BUY
$6.84 - $11.91 $258,941 - $450,876
37,857 Added 473.63%
45,850 $471,000
Q1 2023

May 12, 2023
BUY
$7.0 - $8.75 $40,019 - $50,023
5,717 Added 251.19%
7,993 $61,000
Q4 2022

Feb 08, 2023
BUY
$5.45 - $7.35 $12,404 - $16,728
2,276 New
2,276 $16,000
Q2 2022

Aug 10, 2022
SELL
$6.71 - $9.52 $7,843 - $11,128
-1,169 Reduced 49.35%
1,200 $10,000
Q1 2022

May 16, 2022
SELL
$6.41 - $13.89 $16,839 - $36,489
-2,627 Reduced 52.58%
2,369 $22,000
Q4 2021

Feb 14, 2022
BUY
$10.41 - $13.95 $40,120 - $53,763
3,854 Added 337.48%
4,996 $70,000
Q3 2021

Nov 15, 2021
BUY
$8.19 - $11.31 $9,352 - $12,916
1,142 New
1,142 $12,000
Q2 2021

Aug 13, 2021
SELL
$8.81 - $15.03 $6,070 - $10,355
-689 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$10.02 - $13.92 $6,903 - $9,590
689 New
689 $7,000
Q4 2020

Feb 11, 2021
SELL
$7.42 - $15.96 $10,417 - $22,407
-1,404 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$7.15 - $11.5 $2,059 - $3,312
288 Added 25.81%
1,404 $12,000
Q2 2020

Jul 31, 2020
BUY
$2.77 - $12.1 $3,091 - $13,503
1,116 New
1,116 $11,000
Q3 2019

Nov 14, 2019
SELL
$3.5 - $5.0 $3,951 - $5,645
-1,129 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$4.08 - $7.75 $3,533 - $6,711
866 Added 329.28%
1,129 $5,000
Q1 2019

May 14, 2019
SELL
$4.09 - $7.19 $5,779 - $10,159
-1,413 Reduced 84.31%
263 $2,000
Q4 2018

Feb 14, 2019
BUY
$3.68 - $6.07 $6,167 - $10,173
1,676 New
1,676 $6,000
Q3 2018

Nov 14, 2018
SELL
$5.68 - $8.59 $12,138 - $18,356
-2,137 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$7.16 - $10.05 $7,926 - $11,125
1,107 Added 107.48%
2,137 $16,000
Q1 2018

May 15, 2018
BUY
$7.95 - $11.65 $8,188 - $11,999
1,030 New
1,030 $8,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email